PHILADELPHIA, April 19, 2016 /PRNewswire/ -- Clincierge® will showcase the company's unique hospitality-driven services that support clinical trial recruitment and patient retention at World Orphan Drug Congress U.S.A 2016, being held in Washington, DC from April 20 - 22. Additionally, Clincierge® Chief Executive Officer Scott Gray will chair the first day of the Main Conference, April 21.
"Clinical trial sites for Orphan Drug studies are often widely dispersed, making multi-national trials and the necessity of patient travel a significant challenge for sponsors and CROs that can lead to slow recruitment and frequent patient drop-outs," says Scott Gray, chief executive officer of Clincierge®. "By providing patients with high-touch personalized support, regular one-on-one communication, upfront payments/rapid reimbursement, and expert logistical assistance for travel and accommodations, our services have had a dramatically positive effect on recruitment and retention for these complex trials."
Clincierge® will exhibit and be available for discussion at Booth #31 at the World Orphan Drug Congress.
Clincierge® reduces barriers to clinical trial participation, enhancing enrollment and reducing drop-outs. We help put patient needs first, providing personalized support, travel and accommodation logistics, and directly paying trial-related costs outside of reimbursable incidental expenses. Live assistance in the patient's own language helps answer study-related questions or concerns. We readily address special needs and complex trial designs, building custom solutions to specific study-related problems. We operate worldwide in 30 countries and 23 languages, adding service areas and capabilities as needed. Our goal: to reduce clinical testing time and cost, thus helping get new treatments to market as swiftly as possible. For more information on our company and services, please visit our website at http://www.clincierge.com.
Scott A. Gray, CEO
Clincierge®, a division of Gray Consulting International